Peggy Pinkston | Vice President, Investor Relations |
Clay Siegall | President and Chief Executive Officer |
Chip Romp | Executive Vice President, Commercial, U.S. |
Todd Simpson | Chief Financial Officer |
Roger Dansey | Chief Medical Officer |
Michael Schmidt | Guggenheim |
Salveen Richter | Goldman Sachs |
Cory Kasimov | JPMorgan |
Kenan McKay | RBC Capital Markets |
Chad Messer | Needham & Company |
Peter Kim | Barclays |
Andrew Berens | SVB Leerink |
Jay Olson | Oppenheimer |
Greg Harrison | Bank of America |
Andy Hsieh | William Blair |
George Farmer | BMO Capital Markets |
Reni Benjamin | JMP Securities |
Joe Catanzaro | Piper Sandler |
Good day and welcome to the Seattle Genetics Second Quarter 2020 Financial Results Conference Call. Today’s conference is being recorded. At this time, I would like to turn the conference over to Ms. Peggy Pinkston, Vice President, Investor Relations. Please go ahead.